All research
Semaglutide 2022-10-26 ClinicalTrials

Oral Semaglutide vs. Sitagliptin Comparison Planned for Liver Transplant Recipients with Diabetes

Semaglutide vs Sitagliptin

Abstract

Oral Semaglutide is being compared to Sitagliptin for glycemic control, body weight, and safety in liver transplant recipients with poorly-controlled diabetes.

TitrateLab articles covering Semaglutide

Written by TitrateLab, separately from the study summarized above.


Source: clinicaltrials:NCT05195944 · Ingested Oct 20, 2026 · Digest: gemini-2.5-flash